Clinical trial
Transcatheter Tricuspid Valve Replacement (TTVR) in Patients With Severe TR ONgoing Evidence Generation (STRONG) Under Coverage With Evidence Development (CED)
NCT06833476 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transcatheter Tricuspid Valve Replacement (TTVR) in Patients With Severe TR ONgoing Evidence Generation (STRONG) Under Coverage With Evidence Development (CED)
- Lead sponsor
- Edwards Lifesciences
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 19, 2025
- Completion date
- December 31, 2032
- Enrollment
- 2,044 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
tricuspid regurgitation